Predictors of heart failure symptoms in hereditary hemorrhagic telangiectasia patients with hepatic arteriovenous malformations

Abstract Background Hepatic arteriovenous malformations (AVMs) in hereditary hemorrhagic telangiectasia (HHT) patients are most commonly hepatic artery to hepatic venous shunts which can result in high-output heart failure. This condition can be debilitating and is a leading cause of liver transplan...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Lucas R. Cusumano, Joseph A. Tesoriero, Craig B. Wilsen, James Sayre, Matthew Quirk, Justin P. McWilliams
Formato: article
Lenguaje:EN
Publicado: BMC 2021
Materias:
R
Acceso en línea:https://doaj.org/article/6b13cdf3a31a413c89e0e44ba34660a7
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:6b13cdf3a31a413c89e0e44ba34660a7
record_format dspace
spelling oai:doaj.org-article:6b13cdf3a31a413c89e0e44ba34660a72021-11-21T12:26:10ZPredictors of heart failure symptoms in hereditary hemorrhagic telangiectasia patients with hepatic arteriovenous malformations10.1186/s13023-021-02109-41750-1172https://doaj.org/article/6b13cdf3a31a413c89e0e44ba34660a72021-11-01T00:00:00Zhttps://doi.org/10.1186/s13023-021-02109-4https://doaj.org/toc/1750-1172Abstract Background Hepatic arteriovenous malformations (AVMs) in hereditary hemorrhagic telangiectasia (HHT) patients are most commonly hepatic artery to hepatic venous shunts which can result in high-output heart failure. This condition can be debilitating and is a leading cause of liver transplantation in HHT patients. However, it is not known what characteristics can discriminate between asymptomatic patients and those who will develop heart failure symptoms. Results 176 patients with HHT were evaluated with computed tomography angiography (CTA) between April 2004 and February 2019 at our HHT Center of Excellence. 63/176 (35.8%) patients were found to have hepatic AVMs on CTA. 18 of these patients were excluded because of the presence of another condition which could confound evaluation of heart failure symptoms. In the remaining 45 patients included in our cohort, 25/45 (55.6%) patients were classified as asymptomatic and 20/45 (44.4%) were classified as symptomatic, and these groups were compared. In symptomatic patients, mean common hepatic artery (CHA) diameter was significantly higher (11.1 versus 8.4 mm) and mean hemoglobin levels were significantly lower (10.7 vs 12.6 g/dL). A stepwise multiple logistic regression analysis demonstrated that both CHA diameter and hemoglobin level were independent predictors of heart failure symptoms with ORs of 2.554 (95% CI 1.372–4.754) and 0.489 (95% CI 0.299–0.799), respectively. The receiver operator characteristic (ROC) curve of our analysis demonstrated an AUC of 0.906 (95% CI 0.816–0.996), sensitivity 80.0% (95% CI 55.7–93.4%), and specificity 75.0% (95% CI 52.9–89.4%). Conclusions CTA is an effective and easily reproducible method to evaluate hepatic involvement of HHT. Utilizing CTA, clinical, and laboratory data we determined CHA diameter and hemoglobin level were independent predictors of heart failure symptoms.Lucas R. CusumanoJoseph A. TesorieroCraig B. WilsenJames SayreMatthew QuirkJustin P. McWilliamsBMCarticleHereditary Hemorrhagic TelangiectasiaArteriovenous malformationsHigh-output heart failureCommon hepatic arteryComputed tomographyMedicineRENOrphanet Journal of Rare Diseases, Vol 16, Iss 1, Pp 1-7 (2021)
institution DOAJ
collection DOAJ
language EN
topic Hereditary Hemorrhagic Telangiectasia
Arteriovenous malformations
High-output heart failure
Common hepatic artery
Computed tomography
Medicine
R
spellingShingle Hereditary Hemorrhagic Telangiectasia
Arteriovenous malformations
High-output heart failure
Common hepatic artery
Computed tomography
Medicine
R
Lucas R. Cusumano
Joseph A. Tesoriero
Craig B. Wilsen
James Sayre
Matthew Quirk
Justin P. McWilliams
Predictors of heart failure symptoms in hereditary hemorrhagic telangiectasia patients with hepatic arteriovenous malformations
description Abstract Background Hepatic arteriovenous malformations (AVMs) in hereditary hemorrhagic telangiectasia (HHT) patients are most commonly hepatic artery to hepatic venous shunts which can result in high-output heart failure. This condition can be debilitating and is a leading cause of liver transplantation in HHT patients. However, it is not known what characteristics can discriminate between asymptomatic patients and those who will develop heart failure symptoms. Results 176 patients with HHT were evaluated with computed tomography angiography (CTA) between April 2004 and February 2019 at our HHT Center of Excellence. 63/176 (35.8%) patients were found to have hepatic AVMs on CTA. 18 of these patients were excluded because of the presence of another condition which could confound evaluation of heart failure symptoms. In the remaining 45 patients included in our cohort, 25/45 (55.6%) patients were classified as asymptomatic and 20/45 (44.4%) were classified as symptomatic, and these groups were compared. In symptomatic patients, mean common hepatic artery (CHA) diameter was significantly higher (11.1 versus 8.4 mm) and mean hemoglobin levels were significantly lower (10.7 vs 12.6 g/dL). A stepwise multiple logistic regression analysis demonstrated that both CHA diameter and hemoglobin level were independent predictors of heart failure symptoms with ORs of 2.554 (95% CI 1.372–4.754) and 0.489 (95% CI 0.299–0.799), respectively. The receiver operator characteristic (ROC) curve of our analysis demonstrated an AUC of 0.906 (95% CI 0.816–0.996), sensitivity 80.0% (95% CI 55.7–93.4%), and specificity 75.0% (95% CI 52.9–89.4%). Conclusions CTA is an effective and easily reproducible method to evaluate hepatic involvement of HHT. Utilizing CTA, clinical, and laboratory data we determined CHA diameter and hemoglobin level were independent predictors of heart failure symptoms.
format article
author Lucas R. Cusumano
Joseph A. Tesoriero
Craig B. Wilsen
James Sayre
Matthew Quirk
Justin P. McWilliams
author_facet Lucas R. Cusumano
Joseph A. Tesoriero
Craig B. Wilsen
James Sayre
Matthew Quirk
Justin P. McWilliams
author_sort Lucas R. Cusumano
title Predictors of heart failure symptoms in hereditary hemorrhagic telangiectasia patients with hepatic arteriovenous malformations
title_short Predictors of heart failure symptoms in hereditary hemorrhagic telangiectasia patients with hepatic arteriovenous malformations
title_full Predictors of heart failure symptoms in hereditary hemorrhagic telangiectasia patients with hepatic arteriovenous malformations
title_fullStr Predictors of heart failure symptoms in hereditary hemorrhagic telangiectasia patients with hepatic arteriovenous malformations
title_full_unstemmed Predictors of heart failure symptoms in hereditary hemorrhagic telangiectasia patients with hepatic arteriovenous malformations
title_sort predictors of heart failure symptoms in hereditary hemorrhagic telangiectasia patients with hepatic arteriovenous malformations
publisher BMC
publishDate 2021
url https://doaj.org/article/6b13cdf3a31a413c89e0e44ba34660a7
work_keys_str_mv AT lucasrcusumano predictorsofheartfailuresymptomsinhereditaryhemorrhagictelangiectasiapatientswithhepaticarteriovenousmalformations
AT josephatesoriero predictorsofheartfailuresymptomsinhereditaryhemorrhagictelangiectasiapatientswithhepaticarteriovenousmalformations
AT craigbwilsen predictorsofheartfailuresymptomsinhereditaryhemorrhagictelangiectasiapatientswithhepaticarteriovenousmalformations
AT jamessayre predictorsofheartfailuresymptomsinhereditaryhemorrhagictelangiectasiapatientswithhepaticarteriovenousmalformations
AT matthewquirk predictorsofheartfailuresymptomsinhereditaryhemorrhagictelangiectasiapatientswithhepaticarteriovenousmalformations
AT justinpmcwilliams predictorsofheartfailuresymptomsinhereditaryhemorrhagictelangiectasiapatientswithhepaticarteriovenousmalformations
_version_ 1718419010813427712